Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

363.71

392.28

-28.57

-7.28%

Other Operating Income

0.00

Total Operating income

363.71

392.28

-28.57

-7.28%

Raw Material Cost

80.31

253.56

-173.25

-68.33%

Purchase of Finished goods

24.56

0.00

24.56

(Increase) / Decrease In Stocks

-8.65

-16.90

8.25

48.82%

Employee Cost

60.39

58.92

1.47

2.49%

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

-0.01

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

107.50

48.18

59.32

123.12%

Total Expenditure (Excl Depreciation)

264.11

343.77

-79.66

-23.17%

Operating Profit (PBDIT) excl Other Income

99.60

48.51

51.09

105.32%

Other Income

3.88

26.10

-22.22

-85.13%

Operating Profit (PBDIT)

103.48

74.61

28.87

38.69%

Interest

0.14

2.48

-2.34

-94.35%

Exceptional Items

31.80

0.00

31.80

Gross Profit (PBDT)

135.14

72.13

63.01

87.36%

Depreciation

6.02

12.80

-6.78

-52.97%

Profit Before Tax

129.12

59.34

69.78

117.59%

Tax

32.97

14.50

18.47

127.38%

Provisions and contingencies

0.00

Profit After Tax

96.15

44.84

51.31

114.43%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

96.15

44.84

51.31

114.43%

Equity Capital

16.60

30.62

-14.02

-45.79%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

57.92

2.93

54.99

1,876.79%

Diluted Earnings per share

57.92

2.93

54.99

1,876.79%

Operating Profit Margin (Excl OI)

27.38%

12.37%

0.00

15.01%

Gross Profit Margin

37.16%

18.39%

0.00

18.77%

PAT Margin

26.44%

11.43%

0.00

15.01%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 363.71 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -1.82% vs -0.91% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 96.15 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 1.64% vs 21.92% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 99.60 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -26.54% vs 22.75% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Quarterly - Interest

Interest 0.14 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -33.33% vs 110.00% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.38%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025